According to the previous findings, the present study aimed to assess visnagin’s capability in ameliorating rheumatoid arthritis synovial inflammation by inhibiting malate dehydrogenase enzyme (MDH1). This evidence concerns the gene MDH1 and rheumatoid arthritis.